You are here
Manhattan Street Capital Blog
Browse Categories
Regulation A+ (Reg A+) is best described as a capital-raising method rather than a "tool." It is a legal framework established by the Securities and Exchange Commission (SEC) that allows companies to raise capital from a broad range of investors, including both accredited and non-accredited...
Regulation A+ has significant advantages;
Regulation A+ allows startups and mid-stage companies to use equity crowdfunding platforms (such as Manhattan Street Capital)...
Use the Chapters list below to select the part of the video you want to watch.
Chapters:
Introduction – Manhattan Street Capital
Introduction - Naif Hajjar
Agenda...
Newest Reg D offerings on Manhattan Street Capital. For Accredited Investors only.
KGEM Golf
Investors in KGEM Golf will receive an 8% annual dividend, paid monthly...
New and Updated Offerings live on Manhattan Street Capital
ERC Homebuilders
Investors in ERC Homebuilders receive an 8% per annum dividend, paid monthly from the date of...
CLICK HERE to read this article written by Rod Turner for Forbes.
Let’s face it – the IPO window opens and closes in a rather difficult to predict manner. 2015 was a...
What is an Accredited Investor?
To be an Accredited Investor you must meet the criteria laid down in Rule 501 under the Securities Act of 1933, which defines an...
Use the Chapters list below to select the part of the video you want to watch.
Please read the disclaimer below the index
Chapters:
Rod's introduction
About...
Identify Sensors Biologics
A highly accurate, portable, and reusable COVID self-test for smartphones
Purdue University and IdentifySensors Biologics have partnered to...
CLICK HERE to read this article written by Rod Turner for Forbes.
Historically, the window for large and mid-cap company IPOs opens and closes like a heart valve,...
Genprex Cancer IPO launch, Muscle Maker Grill Reg A+ IPO, InsituBiologics RegD Biotech near its goal
Genprex is raising capital through their IPO to progress Clinical trials for their Gene Therapy lung cancer treatment.
Genprex has developed Oncoprex, a unique medicine...
Click here to read this article written by Rod Turner for Forbes.
Two companies used Regulation A+ to conduct their IPOs over the last two weeks, one listed on the NYSE...
ERC Homebuilders Inc. - Max raise $50mill. Anyone can invest
ERC develops "build-to-rent" homes to capitalize on market demand driven by the cultural wave of millennials...
Myomo Completes It’s IPO, The First Regulation A+ Offering To List On The NYSE
CLICK HERE to read this article written by Rod Turner for Forbes.
Myomo, a medical...
I am pleased to announce two new offerings on Manhattan Street Capital, TransCode Therapeutics and GolfSuites 1, and update you on our platform's ongoing offerings....
Reg A+ offerings - Anyone can invest
GolfSuites 1 - Anyone can invest
"GolfSuites is a new investment opportunity focused on bringing hybrid-golf...